US EditionPublished • loading... • Updated
Cheplapharm-Cfo: "the Textbook Calls This Also Growth Pain
Summary by Finance-magazin.de
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
Faster, higher, further – that was the only motto for Cheplapharm for a long time. But now sand has come into the gearbox. CFO Kia Parssanedjad reports how the turnaround of the pharmaceutical company should succeed.
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
